GLOW

Evidence / context

Evidence: Limited. Skin/recovery blend where the fixed GHK-Cu, BPC-157, and TB500 ratio should match the goal.

Blend composition

• BPC-157 10 mg
• TB500 10 mg
• GHK-Cu 50 mg

Available vial formats

Reconstitution

Dosing, cycle & timing

• Conservative 10 units per injection once daily; delivers BPC 333 mcg + TB500 333 mcg + GHK-Cu 1.67 mg per injection
• Standard 15 units per injection once daily; delivers BPC 500 mcg + TB500 500 mcg + GHK-Cu 2.5 mg per injection
• Aggressive 20 units per injection once daily short-term only; delivers BPC 667 mcg + TB500 667 mcg + GHK-Cu 3.33 mg per injection
• Cycle length 12-24 weeks, then reassess
• Best timing Morning or early afternoon once daily.

Timing: Use consistent daily timing during the cycle. Inject slowly and rotate sites. Avoid late dosing if local irritation or GHK-Cu sting disrupts sleep.

Support / expected effects

• Tissue-repair support with a cosmetic/skin-quality angle
• Soft-tissue recovery where convenience matters
• Single-vial recovery blend when separate dosing flexibility is less important

Side effects / tolerability

• Local burning or stinging from the GHK-Cu component
• Injection-site redness or welting
• Mild fatigue or headache

Notes

• Fixed GHK-Cu ratio is convenient but less flexible than separate vials.
• Local GHK-Cu tolerance can limit the whole blend.
• Combined-formulation evidence is less direct than evidence for individual components.

Practical tips

• Use the 3.0 mL setup consistently; adjust injection volume by dose rather than applying 5 mL math.
• Do not force the blend if GHK-Cu sting becomes the limiting factor
• Convenience is the reason to use this blend; flexibility is the reason not to

Related peptides

Related categories

FAQ